From LexBot twenty-four seven, the Trump administration has moved to significantly reduce federal restrictions on medical marijuana. The acting attorney general has reclassified state-licensed medical marijuana from Schedule One to Schedule Three under federal drug laws. This represents a major shift in how the federal government categorizes medical cannabis, moving it from the most restrictive category to a less restrictive classification. The change means medical marijuana businesses operating under state licenses will now benefit from substantial tax advantages they previously couldn't access due to the stricter federal scheduling. Here in Kentucky, where medical marijuana was legalized by the state legislature, this federal reclassification could have important implications for the implementation of the commonwealth's medical cannabis program. The move marks one of the most significant changes to federal marijuana policy in decades, potentially easing the conflict between state and federal law that has created uncertainty for medical marijuana programs across the country.

Listen live: The Lexington Times runs a 24/7 local news livestream — watch on YouTube or on Facebook. This transcript is from a recent on-air segment.